Epic Update : IPCA Laboratories

IPCA Laboratories has entered into an agreement with Avik Pharmaceutical (Avik) to acquire 50% of its paid-up equity share capital, partly through purchase of equity shares from its existing shareholders and partly thru subscription to its fresh equity share capital on a preferential allotment basis, both aggregating to approximately Rs 6.51 crore.

http://www.epicresearch.co/